181 related articles for article (PubMed ID: 11952051)
1. Total thyroidectomy for the treatment of hyperthyroidism in patients with ophthalmopathy.
Kurihara H
Thyroid; 2002 Mar; 12(3):265-7. PubMed ID: 11952051
[TBL] [Abstract][Full Text] [Related]
2. Thyroid surgery for Graves' disease and Graves' ophthalmopathy.
Liu ZW; Masterson L; Fish B; Jani P; Chatterjee K
Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD010576. PubMed ID: 26606533
[TBL] [Abstract][Full Text] [Related]
3. Postoperative changes in thyrotropin-binding inhibitory immunoglobulin level in patients with Graves' disease: is subtotal thyroidectomy a suitable therapeutic option for patients of childbearing age with Graves' disease?
Sugino K; Ito K; Ozaki O; Mimura T; Iwasaki H; Wada N
World J Surg; 1999 Jul; 23(7):727-31. PubMed ID: 10390595
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of rituximab treatment for thyroid-associated ophthalmopathy as a result of intraorbital B-cell depletion in one patient unresponsive to steroid immunosuppression.
Salvi M; Vannucchi G; Campi I; Rossi S; Bonara P; Sbrozzi F; Guastella C; Avignone S; Pirola G; Ratiglia R; Beck-Peccoz P
Eur J Endocrinol; 2006 Apr; 154(4):511-7. PubMed ID: 16556712
[TBL] [Abstract][Full Text] [Related]
5. Preoperative change of thyroid stimulating hormone receptor antibody level: possible marker for predicting recurrent hyperthyroidism in patients with Graves' disease after subtotal thyroidectomy.
Sugino K; Mimura T; Ozaki O; Iwasaki H; Wada N; Matsumoto A; Ito K
World J Surg; 1996 Sep; 20(7):801-6; discussion 806-7. PubMed ID: 8678954
[TBL] [Abstract][Full Text] [Related]
6. Surgical treatment of Graves' disease: subtotal or total thyroidectomy?
Miccoli P; Vitti P; Rago T; Iacconi P; Bartalena L; Bogazzi F; Fiore E; Valeriano R; Chiovato L; Rocchi R; Pinchera A
Surgery; 1996 Dec; 120(6):1020-4; discussion 1024-5. PubMed ID: 8957489
[TBL] [Abstract][Full Text] [Related]
7. The combination of absent thyroid peroxidase antibodies and high thyroid-stimulating immunoglobulin levels in Graves' disease identifies a group at markedly increased risk of ophthalmopathy.
Khoo DH; Ho SC; Seah LL; Fong KS; Tai ES; Chee SP; Eng PH; Aw SE; Fok AC
Thyroid; 1999 Dec; 9(12):1175-80. PubMed ID: 10646655
[TBL] [Abstract][Full Text] [Related]
8. A study of the change in serum TBII before and after subtotal thyroidectomy for hyperthyroidism.
Hoshi T
Fukushima J Med Sci; 1985 Jun; 31(1):1-16. PubMed ID: 2867960
[No Abstract] [Full Text] [Related]
9. Relationship between Graves' ophthalmopathy and type of treatment of Graves' hyperthyroidism.
Marcocci C; Bartalena L; Bogazzi F; Bruno-Bossio G; Pinchera A
Thyroid; 1992; 2(2):171-8. PubMed ID: 1525588
[TBL] [Abstract][Full Text] [Related]
10. Significance of values of thyrotropin binding inhibitor immunoglobulins and appearance of intrathyroidal lymphocytes at subtotal thyroidectomy for Graves' disease.
Kasuga Y; Sugenoya A; Kobayashi S; Shimizu T; Onuma H; Shingu K; Asanuma K; Hama Y; Iida F
J Am Coll Surg; 1994 Jun; 178(6):589-94. PubMed ID: 7910771
[TBL] [Abstract][Full Text] [Related]
11. Surgical treatment of hyperthyroidism: a ten-year experience.
Werga-Kjellman P; Zedenius J; Tallstedt L; Träisk F; Lundell G; Wallin G
Thyroid; 2001 Feb; 11(2):187-92. PubMed ID: 11288990
[TBL] [Abstract][Full Text] [Related]
12. Randomized clinical trial of bilateral subtotal thyroidectomy versus total thyroidectomy for Graves' disease with a 5-year follow-up.
Barczyński M; Konturek A; Hubalewska-Dydejczyk A; Gołkowski F; Nowak W
Br J Surg; 2012 Apr; 99(4):515-22. PubMed ID: 22287122
[TBL] [Abstract][Full Text] [Related]
13. Thyroidectomy remains an effective treatment option for Graves' disease.
Weber KJ; Solorzano CC; Lee JK; Gaffud MJ; Prinz RA
Am J Surg; 2006 Mar; 191(3):400-5. PubMed ID: 16490555
[TBL] [Abstract][Full Text] [Related]
14. Cloning and characterization of the novel thyroid and eye muscle shared protein G2s: autoantibodies against G2s are closely associated with ophthalmopathy in patients with Graves' hyperthyroidism.
Gunji K; De Bellis A; Li AW; Yamada M; Kubota S; Ackrell B; Wengrowicz S; Bellastella A; Bizzarro A; Sinisi A; Wall JR
J Clin Endocrinol Metab; 2000 Apr; 85(4):1641-7. PubMed ID: 10770210
[TBL] [Abstract][Full Text] [Related]
15. Surgical management of hyperthyroidism.
Quérat C; Germain N; Dumollard JM; Estour B; Peoc'h M; Prades JM
Eur Ann Otorhinolaryngol Head Neck Dis; 2015 Apr; 132(2):63-6. PubMed ID: 25592327
[TBL] [Abstract][Full Text] [Related]
16. Changes in serum TSH receptor antibody (TRAb) values in patients with Graves' disease after total or subtotal thyroidectomy.
Takamura Y; Nakano K; Uruno T; Ito Y; Miya A; Kobayashi K; Yokozawa T; Matsuzuka F; Kuma K; Miyauchi A
Endocr J; 2003 Oct; 50(5):595-601. PubMed ID: 14614216
[TBL] [Abstract][Full Text] [Related]
17. Should the primary treatment of hyperthyroidism be surgical?
Linos DA; Karakitsos D; Papademetriou J
Eur J Surg; 1997 Sep; 163(9):651-7. PubMed ID: 9311471
[TBL] [Abstract][Full Text] [Related]
18. [The relationship between serum thyroid autoantibodies, iodine intake, development and prognosis of Graves' disease].
Chen W; Man N; Li YS; Shan ZY; Teng WP
Zhonghua Nei Ke Za Zhi; 2006 Feb; 45(2):95-9. PubMed ID: 16624113
[TBL] [Abstract][Full Text] [Related]
19. Changes in thyroid function and immunological parameters long after subtotal thyroidectomy for Graves' disease.
Kasuga Y; Kobayashi S; Fujimori M; Shingu K; Asanuma K; Hama Y; Ito K; Maruyama M; Amano J
Eur J Surg; 1998 Mar; 164(3):173-8. PubMed ID: 9562276
[TBL] [Abstract][Full Text] [Related]
20. Clinical results of anti-inflammatory therapy in Graves' ophthalmopathy and association with thyroidal autoantibodies.
Eckstein AK; Plicht M; Lax H; Hirche H; Quadbeck B; Mann K; Steuhl KP; Esser J; Morgenthaler NG
Clin Endocrinol (Oxf); 2004 Nov; 61(5):612-8. PubMed ID: 15521965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
